{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.31 vs. cons $1.29",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth",
      "prediction": "BEAT",
      "answer": "pred ~6.5% vs. cons 6.1%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Orders growth",
      "prediction": "BEAT",
      "answer": "pred ~22% vs. cons 20%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$4.85 vs. cons $4.88 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Implied fiscal 4Q26 adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide ~$1.46 vs. cons $1.49 (4Q26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 organic sales-growth guidance",
      "prediction": "LOWER",
      "answer": "guide ~6.0% vs. cons 6.2% (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Backlog conversion in the next 12 months",
      "prediction": "LOWER",
      "answer": "guide ~70% vs. cons 72% (next 12 months)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest 3Q beat is likely outweighed by unchanged FY26 EPS of ~$4.85 versus ~$4.88 consensus, implying ~$1.46 for 4Q26 versus ~$1.49. That out-period shortfall, together with continued ~70% backlog-conversion timing, should pull FY26/FY27 revisions lower after the report.",
  "day5_confidence": "MEDIUM"
}